HCW Biologics Inc. (NASDAQ:HCWB – Get Free Report) was the target of a significant drop in short interest in the month of February. As of February 28th, there was short interest totalling 543,700 shares, a drop of 34.9% from the February 13th total of 835,500 shares. Based on an average daily volume of 5,830,000 shares, the short-interest ratio is currently 0.1 days. Currently, 2.1% of the shares of the company are sold short.
HCW Biologics Stock Performance
HCW Biologics stock traded up $0.01 during midday trading on Friday, reaching $0.34. 101,220 shares of the company’s stock were exchanged, compared to its average volume of 7,581,969. HCW Biologics has a 52 week low of $0.21 and a 52 week high of $2.52. The firm has a market cap of $15.14 million, a price-to-earnings ratio of -0.34 and a beta of 0.71. The stock’s 50-day simple moving average is $0.38 and its 200 day simple moving average is $0.46.
HCW Biologics Company Profile
Further Reading
- Five stocks we like better than HCW Biologics
- Overbought Stocks Explained: Should You Trade Them?
- How to Build the Ultimate Everything ETF Portfolio
- Airline Stocks – Top Airline Stocks to Buy Now
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Upcoming IPO Stock Lockup Period, Explained
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for HCW Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCW Biologics and related companies with MarketBeat.com's FREE daily email newsletter.